ProKidney Corp.
NASDAQ · us_market
No AI insight generated yet for this ticker.
ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008 which are both in Phase III clinical trials; REGEN-002, REGEN-003, and REGEN-007 which are in Phase II clinical trials; and REGEN-004 which is Phase I clinical trial. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| RenTech | quant | 1.25M | $2.24M | 0.00% | Added+39.6% | 2026-03-31 |
| StateStreet | passive | 556.8K | $996.75K | 0.00% | Added+15.9% | 2026-03-31 |
| TwoSigma | quant | 346.4K | $620.02K | 0.00% | Trimmed-25.6% | 2026-03-31 |
| Citadel | multi-strat | 65.6K | $117.39K | 0.00% | Added+283.8% | 2026-03-31 |
| FidelityFMR | fundamental | 10.3K | $18.36K | 0.00% | Trimmed-0.5% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-12upcoming | — | — | — |
| 2026-05-15 | -0.14 | -0.14 | -1.83% |
| 2026-03-18 | -0.15 | -0.14 | +7.33% |
| 2025-11-10 | -0.14 | -0.12 | +11.88% |
| 2025-08-12 | -0.14 | -0.13 | +10.03% |
| 2025-05-12 | -0.15 | -0.13 | +15.22% |
| 2025-03-17 | -0.14 | -0.17 | -21.62% |
| 2024-11-12 | -0.22 | -0.14 | +35.42% |
| 2024-08-09 | -0.18 | -0.16 | +10.25% |
| 2024-05-10 | -0.18 | -0.16 | +10.81% |
| 2024-03-22 | -0.18 | -0.09 | +50.15% |
| 2023-11-14 | -0.14 | -0.18 | -25.78% |
| 2023-08-10 | -0.41 | -0.14 | +66.03% |
| 2023-05-11 | -0.12 | -0.16 | -30.54% |
| 2023-03-28 | -0.30 | -0.11 | +63.52% |
| 2022-11-14 | -0.31 | -0.13 | +57.70% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| PROK | -5.18% | -25.61% | -18.30% | +145.31% |
| XLV | +2.97% | -4.83% | -3.44% | +12.62% |
| Alpha (stock − sector) | -8.15% | -20.78% | -14.86% | +132.69% |